活體移植市場動向

Abstract

Biological Implants report analyzes the market for biological implant procedures. The total biological implants market is analyzed by tissue/muscle; origin, and mode of administration at global level and for each of the geographic regions - North America, Europe, Asia-Pacific and Rest of World. The biological implants market is segmented by Tissue/Muscle into Soft Tissue, Orthopedic, Cardiovascular and Other (includes Dental, Ophthalmic, and Urologic); by Origin into Allograft, and Xenograft; and by Mode of Administration into Injectable and Surgical.

Business profiles of 27 major companies are discussed in the report. The report serves as a guide to global biological implants industry covering 164 companies that are engaged in biological implants' processing, R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Projections and estimates are graphically illustrated by geographic region with exclusive graphical representations provided for 241 exhibits.

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Foreword

• Biological Implants - A Revolutionary Human Repair Technique
  • Segmentation of Biological Implants
    • Exhibit 1: Segmentation of Global Biological Implants Market by Tissue/Muscle (Orthopedic, Soft Tissue, Cardiovascular, and Other*), by Origin (Allograft and Xenograft) and by Mode of Administration (Surgical and Injectable)

2. Global Market Analysis

• Exhibit 2: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
• Medical Implants
  • An Overview of Medical Implants
  • History of Implants
  • The Need for a Better Implant
  • Naturally Derived Implants
  • Orbital Implants and Artificial Eyes
  • Artificial Skin
  • Hip Replacement
• Tissues
  • Animal Tissues
  • Plant Tissues
• Definitions
  • Implant
  • Transplant
  • Explant
  • Types of Implants
    • Artificial Implants
    • Biological Implants
  • Tissue Engineering
  • Market Analysis of Tissue/Muscle Biological Implants by Geographic Region
    • Orthopedic
      • Exhibit 3: Orthopedic Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 4: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 5: Soft Tissue Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 6: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 7: Cardiovascular Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 8: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 9: Biological Implants in Other Tissue/Muscle (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 10: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Market Analysis of Origin by Geographic Region
    • Allograft
      • Exhibit 11: Allograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 12: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Xenograft
      • Exhibit 13: Xenograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 14: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Market Analysis of Mode of Administration by Geographic Region
    • Surgical
      • Exhibit 15: Surgical Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 16: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Injectable
      • Exhibit 17: Injectable Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 18: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
      • Exhibit 19: List of Major Global Companies

3. Regional Market Analysis

• North America
  • Exhibit 20: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Major Companies in North America
    • Aastrom Biosciences, Inc. (USA)
    • Alphatec Spine, Inc. (USA)
    • CONMED Linvatec (USA)
    • CryoLife®, Inc. (USA)
    • Curis, Inc. (USA)
    • Exactech, Inc. (USA)
    • Fascia Biosystems LLC (USA)
    • Inamed Aesthetics (USA)
    • Integra Lifesciences Corporation (USA)
    • IOP, Inc. (USA)
    • LifeCell Corporation (USA)
    • Nuvasive, Inc (USA)
    • Organogenesis, Inc. (USA)
    • Osteotech, Inc. (USA)
    • Pegasus Biologics, Inc. (USA)
    • QLT Inc. (Canada)
    • Stryker Corporation (USA)
    • Tutogen Medical, Inc. (USA)
  • Market Analysis by Tissue / Muscle Biological Implants in North America
    • Ortopedic
      • Exhibit 21: Ortopedic Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 22: Ortopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • SoftTissue
      • Exhibit 23: SoftTissue Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 24: SoftTissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 25: Cardiovascular Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 26: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 27: Biological Implants in Other Tissue/Muscle (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 28: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Market Analysis by Origin in North America
    • Allograft
      • Exhibit 29: Allograft Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 30: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Xenograft
      • Exhibit 31: Xenograft Biological Implants (2005-2012) - North American Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 32: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Market Analysis by Mode of Administration in North America
    • Surgical
      • Exhibit 33: Surgical Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 34: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Injectable
      • Exhibit 35: Injectable Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 36: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Europe
  • Exhibit 37: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Major Companies in Europe
    • M Arthro Kinetics plc (UK)
    • Asterand Plc (UK)
    • AutoTissue GmbH (Germany)
    • BioTissue Technologies AG (Germany)
  • Market Analysis by Tissue / Muscle in Europe
    • Orthopedic
      • Exhibit 38: Orthopedic Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 39: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 40: Soft Tissue Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 41: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 42: Cardiovascular Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 43: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 44: Biological Implants in Other Tissue / Muscle(2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 45: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
  • Market Analysis by Origin in Europe
    • Allograft
      • Exhibit 46: Allograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 47: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Xenograft
      • Exhibit 48: Xenograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 49: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
  • Market Analysis by Mode of Administration in Europe
    • Surgical
      • Exhibit 50: Surgical Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 51: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Injectable
      • Exhibit 52: Injectable Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 53: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
    • Asia-Pacific
      • Exhibit 54: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  • Major Companies in Asia-Pacific
  • bioMD Limited (Australia)
  • Maxigen Biotech, Inc. (Taiwan)
  • Market Analysis by Tissue / Muscle in Asia-Pacific
    • Orthopedic
      • Exhibit 55: Orthopedic Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 56: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 57: Soft Tissue Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 58: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 59: Cardiovascular Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 60: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 61: Biological Implants in Other Tissue / Muscle (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 62: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
  • Market Analysis by Origin in Asia-Pacific
    • Allograft
      • Exhibit 63: Allograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 64: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Xenograft
      • Exhibit 65: Xenograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 66: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
  • Market Analysis by Mode of Administration in Asia-Pacific
    • Surgical
      • Exhibit 67: Surgical Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 68: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Injectable
      • Exhibit 69: Injectable Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 70: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
    • Rest of World
      • Exhibit 71: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
  • Market Analysis by Tissue/Muscle in Rest of World
    • Orthopedic
      • Exhibit 72: Orthopedic Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 73: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World (Graphical Representation Included)
    • Soft Tissue
      • Exhibit 74: Soft Tissue Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 75: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Cardiovascular
      • Exhibit 76: Cardiovascular Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 77: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Other (Dental, Ophthalmic and Urologic)
      • Exhibit 78: Biological Implants in Other Tissue / Muscle (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 79: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
  • Market Analysis by Origin in Rest of World
    • Allograft
      • Exhibit 80: Allograft Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 81: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Xenograft
      • Exhibit 82: Xenograft Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 83: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Market Analysis by Mode of Administration in Rest of World
    • Surgical
      • Exhibit 84: Surgical Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 85: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
    • Injectable
      • Exhibit 86: Injectable Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and *Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 87: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)

III. PRODUCT/TECHNOLOGY RESEARCH

1. Introduction

• Biological Implants Growth Trends - Global Markets
  • Exhibit 88: Global Market for Biological Implants: Geographic Regions (North America, Europe, Asia-Pacific, Rest of World) Ranked by Projected CAGR for 2005 through 2012(Graphical Representation Included)
• Types of Biological Implants
• Application Biological Implants
  • Function and Use of Biological Implants
  • Application of Biological Implants in ENT surgery
    • Location of the Bioimplant: Middle Ear
      • Ossicle Replacement Draws Mixed Response
      • Tympanoplasty
      • Traumatic Perforation Using Fibrin-coated Collagen
    • Location of the Bioimplant: Paranasal Sinuses and Cranial Bones
      • Orbital Wall Reconstructions Using Allogenic Materials
    • Location of the Bioimplant: Bone and Cartilage of the Nose
      • Allogenic Materials to Develop Cartilage
      • Septal Abscess
      • Soft Tissue Implants
    • Location of the Bioimplant: Base of the Skull
      • Allogenic Materials to Treat Dural Defects
      • Allogenic Materials Required to Accomplish Duraplasty
      • The Application of Fibrin Glues in ENT Surgeries
    • Location of the Bioimplant: Trachea/Larynx
      • The Replacement of Trachea Using Solvent-preserved Allogenic Variety of Trachea
      • The Various Disorders of Vocal Cord
    • Location of the Bioimplant: Skin
      • The Process of Skin Replacement
      • Wrinkle Lift Treatment

2. Segmentation of Biological Implants

• Segmentation by Tissue/Muscle
  • Growth Trends - Global Market for Biological Implants by Tissue /Muscle
    • Exhibit 89: Global Market for Biological Implants by Tissue / Muscle (Other, Soft Tissue, Orthopedic, and Cardiovascular) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Soft Tissue Biological Implants
  • Growth Trends - Global Market for Soft Tissue Biological Implants
    • Exhibit 90: Global Market for Soft Tissue Biological Implants: Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Biological Implants in Cosmetic Surgery
  • Lip Augmentation Using Bioimplants
  • Allograft Implants Used in Lip Augmentation
  • Types and Characteristics of Various Allograft Implants
    • Alloderm
    • Apligraft
    • Cosmoderm 1 & 2
    • Cosmoplast
    • Cymetra or Micronized Alloderm
    • Fascian
  • Surgisis Soft Tissue Graft & Surgisis ES Soft Tissue Graft
  • Self Derived [Autologous] Implants & Injectables
  • Types and Characteristics of Autologous Implants
    • Autologen
    • Dermis Grafts
    • Dermis Fat Grafts
    • Fascia Grafts
    • Fat Grafting, Transfer or Transplanting
    • Isolagen
    • Scar Tissue Grafting
    • Tendon Grafting
• Cosmetic Surgery
  • Global Market Analysis for Cosmetic Surgery
    • Exhibit 91: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    • Exhibit 92: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) for Cosmetic Surgery in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
    • Exhibit 93: Cosmetic Surgery (2006, 2009 and 2012) - Percentage Breakdown for Cosmetic Surgery in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
  • Orthopedic Biological Implants
    • Growth Trends - Global Market for Orthopedic Biological Implants
      • Exhibit 94: Global Market for Orthopedic Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
      • Bone Graft Substitutes
      • Osteoinductive Agents - Substitute for Bone Allografts
      • Fibrin Matrix
  • Cardiovascular Biological Implants
    • Growth Trends - Global Market for Cardiovascular Biological Implants
      • Exhibit 95: Global Market for Cardiovascular Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Other (Dental, Ophthalmic, Urologic)
    • Growth Trends - Global Market for Biological Implants in Other Tissue/Muscle
      • Exhibit 96: Global Market for Biological Implants in other Tissue/Muscle: Geographic Region (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
      • Other Tissue/Muscle Biological Implant Products
      • Ophthalmic Biological Implants

3. Segmentation by Origin of Biological Implants

• Growth Trends - Global Market for Biological Implants by Origin
  • Exhibit 97: Global Market for Biological Implants by Origin (Xenograft, Alloraft) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Allograft and Xenograft Biological Implants
  • Autografts and their Limitations
  • Utilization of the Allograft Bone Tissue
  • Limitations of the Process
• Few Disadvantages of Using Allografts
• Preventive Measures for Warding Infection
• Bone Grafting
  • Xenografts
  • Using Valved Porcine Xenografts in the Right Ventricle Outlet for Congenital Anomalies
  • Other Avenues of Research
  • The L-Hydro Method
• Allograft Biological Implants
  • Growth Trends - Global Market for Allograft Biological Implants
    • Exhibit 98: Global Market for Allograft Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Xenograft Biological Implants
  • Growth Trends - Global Market for Xenograft Biological Implants
    • Exhibit 99: Global Market for Xenograft Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
    • Allograft Bone Tissue - Processing
      • Preparation for Biotransplantation
    • Allograft Bone Tissue
    • Base Tissue Segment
      • The Processing of Allograft Bone Tissue
      • Processing of Grafton® DBM - A Biological Implant Product of Osteotech
    • CXC Technology
      • The Process of Tissue Processing Using Tutogen
      • The Process of Manufacture and Processing of Allografts
• Stentless Porcine Xenograft (Mitral Valve Replacement)

4. Segmentation by Mode of Administration

• Growth Trends - Global Market for Biological Implants by Mode of Administration
  • Exhibit 100: Global Market for Biological Implants by Mode of Administration (Injectable and Surgical) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
• Injectable Biological Implants
  • Growth Trends - Global Market for Injectable Biological Implants
    • Exhibit 101: Global Market for Biological Implants by Mode of Administration : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  • Injectable Fillers for Soft Tissue Augmentation
    • Types of Augmentation Materials
  • Osteogenic Injectable Bone Substitutes
• Surgical Biological Implants
  • Growth Trends - Global Market for Surgical Biological Implants
    • Exhibit 102: Global Market for Surgical Biological Implants : Geographic Regions (Europe, Asia-Pacific, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

5. Product Trends

• Research and Development
  • Neovascularisation Promoting Membrane for Biological Implants
  • Biological Implants of Semipermeable Amphiphilic Membranes
  • Artificial Tissue Systems
  • Stem Cells in Biological Implants
    • The Journey of Embryonic Stem Cells from Fundamental Biology to Medicine
    • Application of Umbilical Cord Lining Cells as Therapeutic Bioimplants for Metabolic Disorders
  • Drug Delivery and Smart Biological Implants
  • Tissue Engineered Biological Implants
  • Biological Implants Treatment of Vocal Fold Disorders
  • Systemic Inhibition of Tumor Growth using Biological Implants
    • Process of Secretion and Expression of TSP-2 using Polymer-Cell Grafts in Vivo
    • Inhibition of Tumor Growth in Mice Containing TSP-2-secreting Bioimplants.
    • Inhibition of Tumor Angiogenesis in Mice Containing TSP-2-secreted Bioimplants
  • Surgery for Valvular Heart Disease
  • RVOT Reconstruction
    • Bovine Valved Venous Xenografts for RVOT Reconstruction
  • Alloplastic Implants for Treatment of Stress Urinary Incontinence
  • Repair of Cartilage Lesions
    • Repair of Cartilage Lesions Using Biological Implants - A Comparative Histological and Biomechanical Study in Goats
  • Cryopreservation of Human Ovarian Tissues
  • ADAPT (Advanced Tissue Process) - CXC Technology
• Clinical Trials
  • Man Implanted with Teeth obtained from shoulder!!!!
  • Implantation of Esterified Hyaluronic Acid in Microdissected Reinke' s Space
    • Healing of Brain and Bones
    • Saving Brain and Spines
    • The Perfect Knee
    • Get the Smile Back on Your Face
    • Mending Broken Hearts
• Biological Implants in Sports Medicine
  • Allografts in Sports
• Transplantation Genetics
  • Acceptance of Biological Implants
• Biphasic Implants
  • Preparation of a Biphasic Scaffold
  • Devising Biological Implants for Healing of Joint Disorders
• Biomaterials
  • The Construction of New Body Parts
  • Orthopedic Biomaterials
  • Heart Valve Biomaterials
• Risk of Infection, Off - Label Use and Safety
  • Table: Different Processes Used for Preservation of Allografts and Xenografts
• Ethical Issues Concerning Biological Implants
  • Moral Issue and Balancing Concept
    • Animal Rights
      • “Speciesism”
      • Rights
      • Objectivity
    • Practical Issue
  • Animal-to-Human Transplantation

IV. MARKET DYNAMICS

1. Market Overview

• Global Market Analysis for Implants
  • Exhibit 103: Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
• Global Market Analysis for Spinal Implants
  • Exhibit 104: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 105: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) for Implants in US, Europe, Asia, Canada and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 106: Spinal Implants (2006, 2009 and 2012) - Percentage Breakdown for Implants in USA, Europe, Asia-Pacific, Canada and Rest of World (Graphical Representation Included)
• Global Market Analysis for Orthopedic Implants
  • Exhibit 107: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 108: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) for Orthopedic Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 109: Orthopedic Implants (2006, 2009 and 2012) - Percentage Breakdown for Orthopedic Implants in USA, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
• Global Market Analysis for Cardiovascular Implants
  • Exhibit 110: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 111: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) for Cardiovascular Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 112: Cardiovascular Implants (2006, 2009 and 2012) - Percentage Breakdown for Cardiovascular Implants in USA, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
• Global Market Analysis for Dental Implants
  • Exhibit 113: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 114: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) for Dental Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  • Exhibit 115: Dental Implants (2006, 2009 and 2012) - Percentage Breakdown for Dental Implants in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
• Global Market Analysis for Biological Implants
  • Exhibit 116: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million (Graphical Representation Included)
  • Exhibit 117: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
• Global Market Analysis by Tissue/Muscle
  • Exhibit 118: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
  • Exhibit 119: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)
• Global Market Analysis by Origin
  • Exhibit 120: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
  • Exhibit 121: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Origin for Allograft and Xenograft
• Global Market Analysis by Mode of Administration
  • Exhibit 122: Biological Implants (2005-2012): Global Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
  • Exhibit 123: Biological Implants (2006, 2009 and 2012): Percentage Breakdown of Global Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

2. Market Trends

3. Major Companies in Biological Implants Industry

• Aastrom Biosciences, Inc. (USA)
• Alphatec Spine, Inc. (USA)
• Arthro-Kinetics Plc (UK)
• Asterand Plc (UK)
• AutoTissue GmbH (Germany)
• bioMD Limited (Australia)
• BioTissue Technologies AG (Germany)
• CONMED Linvatec (USA)
• CryoLife, Inc. (USA)
• Curis, Inc. (USA)
• Exactech, Inc. (USA)
• Fascia Biosystems LLC (USA)
• Inamed Aesthetics (USA)
• Inion OY (Finland)
• Integra Lifesciences Corporation (USA)
• IOP, Inc. (USA)
• LifeCell Corporation (USA)
• Maxigen Biotech, Inc. (Taiwan)
• NuVasive Inc. (USA)
• Organogenesis, Inc. (USA)
• Osteotech, Inc. (USA)
• Pegasus Biologics, Inc. (USA)
• QLT, Inc. (Canada)
• Stryker Corporation (USA)
• Tutogen Medical, Inc. (USA)

4. Major Activities in Biological Implants Industry

• Organogenesis Inc. Signs MoU with National Tissue Engineering Center of China
• Tutogen Medical, Inc. Signs New Tissue Supply Agreement and Extends Existing Agreement
• Regeneration Technologies Merges with Tutogen Medical
• Integra Creates a New Global Leader in Orthobiologics with New Acquisition (IsoTis)
• Osteotech Signs Tissue Supply Agreement with LifeNet Health
• RTI Introduces New BioCleanse® Meniscus
• Mentor Launches New NeoForm™ Dermis for Breast Reconstruction
• LifeCell Corporation Receives 510(k) Clearance for New Soft Tissue Repair Product
• RTI Signs Distribution and Supply Agreement with Stryker Corporation
• Inion Granted with US Patent for Bioactive Materials Technology
• Tutogen Medical Signs an International Distribution Agreement with Coloplast Corporation
• Osteotech and Novation sign Single Source Agreement
• Aastrom' s IND Phase III bags FDA approval for Treating Osteonecrosis of the Femoral Head
• ACT Uses Hemangioblasts to Reduce the Risk of Heart Attack
• IsoTis Expands Existing Private Label Agreement with AlloSource for First Generation DBM Products
• RTI Signs Ten Year Distribution Agreement with Zimmer Holdings for New Allograft Paste Implant
• Tutogen Medical Inc. Signs Distribution Agreement with Zimmer Holdings Inc
• Alphatec Holdings Acquires Technology License for Minimally Invasive Spinal Surgery
• Japanese Ministry Endorses Alphatec' s NOVEL Titanium Product Family
• FDA Approval to Exactech for Distribution of Equinox® Reverse Shoulder
• U.S. FDA Grants 510(k) Clearance to Osteotech for Plexur™ P
• Advanced Cell Technology Buys Technology Assets of Infigen
• Bone Regeneration Phase II Clinical Trials Initiated by Kuros
• FDA grants Orphan Drug Designation to Kuros' New Bone Repair Product
• Inion Product Range of BMI Widens with the Approval of ANCHRON™ in Europe
• NuVasive Buys Biologic Product Platform
• License Agreements between Alphatec and Scient' x for Manufacture and Distribution of Spine Implants
• University of Rochester and StemCapture Unveil an Anticancer Stem Cell Implant Device.
• Musculoskeletal Transplant Foundation Announces Three Year Deal with Affinergy
• Bioheart Inc. Expands Clinical Trials of Adult Myogenic Stem Cells
• Encore Medical Acquires Cefar AB of Sweden
• Pegasus Biologics' Wound Dressing Receives FDA Approval
• CryoLife Enters into Alliance with Bioform Medical for Development and Marketing of BioGlue®
• Stem Cell Innovations Enters into Collaboration with ND TWente University for Assessment of Bone Forming Capability of Pluricells
• Exactech Gains FDA Clearance for DBM with Bone Chips, OptecureTM +CCC
• Affinergy Signs Development Agreement with Synthes
• Affinergy Joins Hands with DuPont for New Bio-based Materials
• Acquisition of Exclusive Option Rights of Cell Technology by Bioheart
• Axordia Enters into Collaboration with Lombard Medical Technologies for Developing of Therapy for Coronary Artery Disease
• Smith & Nephew Buys OsteoBiologics Inc.
• Acologix Announces Findings of the Initial Feasibility Study of AC-100
• Bone Growth Stimulator - New Product of Alphatec Holdings.
• Exactech Adds Cemented Stem to its Hip System
• Avecia Given £1m Grant to Develop Bioprocessing Technology for Generating Synthetic Skin for Burn Victims
• Patent Licensing Agreement Signed between Bioheart and Tricardia
• Inion' s Novel Bioactive Technology Granted with US Patent
• Cytori Reveals Outcome of Adipose-derived Stem Cell Therapy
• Alphatec Spine and OsteoBiologics Enter into an Agreement for Distribution of Spine Products.
• Bioheart Signs Agreement to Use Cleveland Clinic' s Proprietary Methods
• Pegasus Launches OrthADAPT™ Bioimplant - a Revolutionary New Biologic Scaffold for Orthopedic Soft Tissue Reinforcement
• Cambrex Buys Cutanogen Corporation
• Inion Enters into Alliance with Aesculap for Distribution of its Spinal Product Range Across the US and Canada
• Inion Enters into an Agreement with the University of Cambridge for Advancement of Bioactive Products
• Total ReCord Initiates Novel treatment for Spinal Cord Injuries
• Inion and Richard Wolf Medical Instruments Enter into Agreement for Distribution of Sports Medicine
• International Distribution Agreement Signed by OsteoBiologics and CONMED Linvatec for Cartilage and Bone Repair Product Range
• Millenium Biologix Enters into License Agreement Exclusively to Improve ACTES(TM)-C
• Inion Launches Biodegradable Spinal Implant in the EU
• OsteoBiologics Enters into Collaboration with Nexa Orthopedics for Surgical Extremities
• Affinergy Awarded SBIR Grant for Research on Medical Device Materials
• Genzyme Acquires Verigen AG
• CryoLife and Endologix Enter into a Development Agreement for BioFoam

5. Regional Market Analysis

• A. NORTH AMERICA
  • Market Analysis
    • Exhibit 124: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 125: List of Major Companies in North America
  • Market Analysis by Geographic Region
    • Exhibit 126: Biological Implants (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Million (Graphical Representation Included)
    • Exhibit 127: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 128: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 129: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular, and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 130: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 131: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 132: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 133: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • North American Biological Implants Market By Country
• A1. United States
  • United States Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 134: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 135: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the US Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 136: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 137: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of US Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 138: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 139: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of US Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• A2. Canada
  • Canadian Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 140: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 141: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 142: Biological Implants (2005-2012) - Canadian Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 143: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 144: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 145: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B. EUROPE
  • Market Analysis
    • Exhibit 146: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 147: List of Major Companies in Europe
  • Market Analysis by Geographic Region
    • Exhibit 148: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
    • Exhibit 149: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 150: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 151: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular, and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 152: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 153: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 154: Biological Implants (2005-2012) -European Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 155: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • European Biological Implants Market By Country
• B1. Germany
  • German Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 156: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 157: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 158: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 159: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 160: Biological Implants (2005-2012) - German Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 161: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B2. The United Kingdom
  • UK Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 162: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million
      • Exhibit 163: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 164: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 165: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 166: Biological Implants (2005-2012) - United Kingdom Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 167: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B3. France
  • French Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 168: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 169: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 170: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million(Graphical Representation Included)
      • Exhibit 171: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 172: Biological Implants (2005-2012) - French Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 173: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B4. Switzerland
  • Swiss Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 174: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 175: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)
    • Analysis by Origin
      • Exhibit 176: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 177: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 178: Biological Implants (2005-2012) - Swiss Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 179: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• B5. Rest of Europe
  • Rest of Europe Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 180: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 181: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 182: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 183: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 184: Biological Implants (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 185: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• C. ASIA-PACIFIC
  • Market Analysis
    • Exhibit 186: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 187: List of Major Companies in Asia-Pacific
  • Analysis by Geographic Region
    • Exhibit 188: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, Japan and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    • Exhibit 189: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, Japan and Rest of Asia-Pacific (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 190: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 191: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Tissue/Muscle for Orthopedic, Soft tissue, Cardiovascular and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 192: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 193: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 194: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 195: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • Asia-Pacific Biological Implants Market By Country
• C.1. Australia
  • Australian Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 196: Biological Implants (2005-2012) - Australian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 197: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 198: Biological Implants (2005-2012) - Australian Market Analysis o(Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 199: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 200: Biological Implants (2005-2012) -Australian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 201: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• C2. Japan
  • Japanese Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 202: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 203: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 204: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 205: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 206: Biological Implants (2005-2012) -Japanese Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 207: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• C3. Rest of Asia-Pacific
  • Rest of Asia-Pacific Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 208: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 209: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 210: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 211: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 212: Biological Implants (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 213: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• D. REST OF WORLD
  • Market Analysis
    • Exhibit 214: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 215: List of Major Companies in Rest of World
  • Analysis by Geographic Region
    • Exhibit 216: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of *World in US$ Million (Graphical Representation Included)
    • Exhibit 217: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and *Rest of World (Graphical Representation Included)
  • Analysis by Tissue/Muscle
    • Exhibit 218: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
    • Exhibit 219: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other (Graphical Representation Included)
  • Analysis by Origin
    • Exhibit 220: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    • Exhibit 221: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
  • Analysis by Mode of Administration
    • Exhibit 222: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
    • Exhibit 223: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
  • Rest of World Biological Implants Market By Country
• D1. Israel
  • Israeli Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 224: Biological Implants (2005-2012) - Israeli Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 225: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 226: Biological Implants (2005-2012) -Israeli Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 227: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 228: Biological Implants (2005-2012) -Israeli Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 229: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Israeli Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• D2.Brazil
  • Brazilian Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 230: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 231: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other
    • Analysis by Origin
      • Exhibit 232: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 233: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 234: Biological Implants (2005-2012) - Brazilian Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 235: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)
• D3. Rest of World (Excluding Israel and Brazil)
  • Rest of World Market Analysis
    • Analysis by Tissue/Muscle
      • Exhibit 236: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Orthopedic, Soft Tissue, Cardiovascular and Other in US$ Million (Graphical Representation Included)
      • Exhibit 237: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other (Graphical Representation Included)
    • Analysis by Origin
      • Exhibit 238: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
      • Exhibit 239: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Origin for Allograft and Xenograft (Graphical Representation Included)
    • Analysis by Mode of Administration
      • Exhibit 240: Biological Implants (2005-2012) - *Rest of World Market Analysis (Current & Future) by Mode of Administration for Surgical and Injectable in US$ Million (Graphical Representation Included)
      • Exhibit 241: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of *Rest of World Market Value by Mode of Administration for Surgical and Injectable (Graphical Representation Included)

6. Biological Implants - The Industry Outlook

V. CORPORATE DIRECTORY